Background: Clear cell renal cell carcinoma (ccRCC) comprises the majority of kidney cancer death worldwide, whose incidence and mortality are not promising. Identifying ideal biomarkers to construct a more accurate prognostic model than conventional clinical parameters is crucial....
The LARCG (Latin American Renal Cancer Group) is a group of scientific and educational, multicentric, multidisciplinary and independent. It is not for profit, and the term of operation is indeterminate. It consists of Urologists, Pathologists and Oncologists, as well as professionals and researchers related to the field of health, belonging to Hospitals in Latin America, Spain and the United States.
In patients with pathologic T1a RCC, patterns of OS differed by surgery and histologic subtype-> Pts receiving partial nephrectomy seem to have better prognosis than both ablation and radical nephrectomy. Weblink: https://t.co/1u8iMGyngb @MABjurlin @UNCurology @AmerUrological
4@SoaresAndrey On Behalf of @larcg_org , our acknowledgment and pleasure in working together #lacog and @SoaresAndrey Rt al., resulting in an advanced kidney cancer guideline from LATAM experts
